The improved response to immunotherapy of EBV-positive GC patients compared to EBV-negative GC patients is hypothesized to be due to increased expression of PD-L1, potentially through activation of the NF-κB pathway by viral protein LMP2A179. Here, CD274 is linked to gastric cancer.